GENEVA, March 23 -- ACROPHARMA AB (c/o MK Capital Invest ABGasverksgatan 3 A222 29 Lund) filed a patent application (PCT/EP2025/075676) for "PEPTIDE AGONISTS OF GPR56" on Sep 09, 2025. With publication no. WO/2026/057585, the details related to the patent application was published on Mar 19, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): SALEHI, Albert (Arkeologvagen 18226 54 Lund)
Abstract: Disclosed are peptides that are useful as agonists of GPR56. Also disclosed are compositions comprising at least two synthetic or recombinant peptides, each of the peptides comprising a sequence select...